; and (ii) that is furnished during the 5-year period beginning on the later of— (I) January 1, 2021; or (II) the date on which the biosimilar biological product is first marketed. (2) Determinations The Secretary shall establish a process— (A) for determining whether an individual is a cost-sharing reduction eligible individual for a year; and (B) for notifying MA organizations of such a determination made with respect to an individual enrolled under an MA plan or MA–PD plan offered by such organization during such year. .